Cardiovascular disease: different strategies for primary and secondary prevention? - Wikidata - wikimedia - TriplyDB

Cardiovascular disease: different strategies for primary and secondary prevention?

Cardiovascular disease: different strategies for primary and secondary prevention?

http://www.wikidata.org/entity/Q35583003

about

Yoga for secondary prevention of coronary heart disease Yoga for secondary prevention of coronary heart disease Yoga for secondary prevention of coronary heart disease Current and Emerging Uses of Statins in Clinical Therapeutics: A Review Keeping a finger on the pulse: Cardiovascular disease rate as a measure of sustainable development Effective policy initiatives to constrain lipid-lowering drug expenditure growth in South Korea Continental-Mediterranean and rural-urban differences in cardiovascular risk factors in Croatian population.Prevention of cardiovascular diseases: focus on modifiable cardiovascular risk Total cardiovascular risk for next 10 years among rural population of Nepal using WHO/ISH risk prediction chart.Erectile dysfunction as a harbinger for increased cardiometabolic risk.Appropriate secondary prevention of acute atherothrombotic events and strategies to improve guideline adherence.A Mediterranean Diet to Improve Cardiovascular and Cognitive Health: Protocol for a Randomised Controlled Intervention Study Preventing coronary heart disease risk of slum dwelling residents in India.Animal models of erectile dysfunction (ED): potential utility of non-human primates as a model of atherosclerosis-induced vascular ED.Targeted quantitation of CVD-linked plasma proteins for biomarker verification and validation.A systematic review of yoga for heart disease.Endogenous Ouabain: An Old Cardiotonic Steroid as a New Biomarker of Heart Failure and a Predictor of Mortality after Cardiac Surgery.Effects of 8-Week Hatha Yoga Training on Metabolic and Inflammatory Markers in Healthy, Female Chinese Subjects: A Randomized Clinical Trial.Antioxidants and Cardiovascular Risk Factors.Impaired Oxidative Status Is Strongly Associated with Cardiovascular Risk Factors.Maternal high-salt diet altered PKC/MLC20 pathway and increased ANG II receptor-mediated vasoconstriction in adult male rat offspring.Subclinical atherosclerosis, cardiovascular health, and disease risk: is there a case for the Cardiovascular Health Index in the primary prevention population?Association between 9p21.3 genomic markers and coronary artery disease in East Asians: a meta-analysis involving 9,813 cases and 10,710 controls.Evaluation of drug interactions between fimasartan and rosuvastatin after single and multiple doses in healthy Caucasians.Oxidative Stress in Muscle Diseases: Current and Future Therapy.Quality indicators for the prevention and management of cardiovascular disease in primary care in nine European countries Patterns of Medicare-funded primary health and specialist consultations in Aboriginal and non-Aboriginal Australians in the two years before hospitalisation for ischaemic heart disease

P2860

Q24186604-0BFA5003-B040-4FA0-A811-8ECED65B8595 Q24187259-3B39C4CB-BAF2-4601-80FA-27D904772BD5 Q24202534-5B4F7203-4F33-48F2-9F49-A7D641A340C4 Q28076346-E16C915B-F7E9-4A2B-8F70-E0136EFAF364 Q30392946-A290BFC8-934B-49D4-98E3-4605F7E8237C Q33586919-FD4F220B-6785-46B4-B63A-419676B19CE0 Q35178417-12AF2AB8-4A85-4901-B796-47470EE9580E Q35770938-4036ADA4-B475-4E76-8F9E-6475B8A72EA9 Q36300145-44399A35-FCEC-495F-8EE0-6F68503B0BD7 Q37058764-73D0C841-D496-4446-AC77-5D63F6485DBD Q37380499-D0558EA3-1458-456A-B502-817653C344F0 Q37673238-0423A57F-0E66-4EBB-9F93-546E821F3357 Q37733392-2F2DB471-F754-414C-A439-7102C53C76FC Q37972086-33C80446-9284-4783-9E17-200956E17EEA Q38160931-36DC9908-4B23-4897-8EB0-10182055B844 Q38184695-ACA248A3-391B-4C7A-A0E3-14CB4A646C03 Q40272490-C2966508-1776-4ABA-AB65-FF6C0ED0A400 Q41733361-A8428DF5-A842-4673-A662-F22904980E2C Q42226794-882727E1-EB55-469E-A4E7-BE9212B05CB2 Q48146386-76C172C8-9E2E-4BF2-9750-04E07481302F Q50527101-AB83C9FC-7B90-4A27-896E-345111069E1E Q51730813-BD728A57-D368-4808-BEF3-56BD3292D0B2 Q53108196-0C681F71-CD93-41F7-94BE-E7BDA1F3D6A4 Q55041037-23BF3CBE-26D9-4477-916F-772795255FBD Q55191328-12CBA56D-CCC6-4567-889F-894D6835A6D8 Q57754076-D8AE1B2C-A018-4540-988F-B6C4981039C1 Q58803169-CC83A38D-25F7-4F09-A377-4C6480BE19F9

P2860

Cardiovascular disease: different strategies for primary and secondary prevention?

http://www.wikidata.org/entity/Q35583003

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Cardiovascular disease: different strategies for primary and secondary prevention?

@ast

Cardiovascular disease: different strategies for primary and secondary prevention?

@en

type

label

Cardiovascular disease: different strategies for primary and secondary prevention?

@ast

Cardiovascular disease: different strategies for primary and secondary prevention?

@en

prefLabel

Cardiovascular disease: different strategies for primary and secondary prevention?

@ast

Cardiovascular disease: different strategies for primary and secondary prevention?

@en

P1433

Q35583003-5213D38E-ADEC-419E-9854-AAC0BB409F6B

P1476

Q35583003-11950CA8-0D34-425F-895D-F7078027CC3C

P2093

Q35583003-A47E76E9-2785-4C0A-BB85-4B9FA147EA73

P2860

Q35583003-0DCAB525-BE07-4D95-8686-03894008E5AA

Q35583003-0FC8C6D2-93B5-4581-BEF0-438506C4C951

Q35583003-455DA60C-FCAA-4AB8-A6B5-B5BBF422D134

Q35583003-4E1301DB-EABA-4570-A66F-573BFD6FB3E8

Q35583003-63C21781-5F5F-4690-85CC-4A926A16C3E7

Q35583003-83EE3629-EC84-441C-97B6-DDC41D1F6B75

Q35583003-A546CC77-DAE5-49CC-BF6E-BF4BF14109CF

Q35583003-A8DCF4B0-76CC-4A1C-899F-AA504385B8CD

Q35583003-AEA9A354-1A40-43B3-9284-EE597298318D

Q35583003-C7B140F8-4B55-4219-8471-B8E6F886555B

P304

Q35583003-D9C48302-C19E-4D90-8DD6-A3C0E03A70AF

P31

Q35583003-4C5069DA-6961-464C-A27E-CA72D6DD2F29

P356

Q35583003-D8DDD3A1-55C2-47C4-854F-7BA543679B6D

P407

Q35583003-18C73E54-1C4E-4741-95B5-9448C96D3E98

P433

Q35583003-217722DB-EBFC-4A37-8639-9B1FD16560BC

P478

Q35583003-0C491B6C-BC3B-4708-B067-04FE9EBA391A

P50

Q35583003-23BE9B8E-0364-4D7F-AB3C-D7D797EC33B0

P577

Q35583003-78044B3B-6344-4BC0-BAA0-2A86BC77D259

P5875

Q35583003-BEE48477-56C2-4128-B29E-B1D830D2CF99

P698

Q35583003-8BD77302-1AF2-4301-9941-1A51E89B59D7

P921

Q35583003-8D8262F5-175C-4ED7-9B42-FA22C368C555

P932

Q35583003-EB6397B0-F0CA-4419-A803-3CF81580F4C2

P356

HRT.2003.027680

P1433

P1476

Cardiovascular disease: different strategies for primary and secondary prevention?

@en

P2093

F D R Hobbs

http://www.w3.org/2001/XMLSchema#string

P2860

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

Mortality in relation to smoking: 40 years' observations on male British doctors

Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

Smoking cessation guidelines for health professionals: an update. Health Education Authority

Concentrations of high density lipoprotein cholesterol, triglycerides, and total cholesterol in ischaemic heart disease.

Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.

P304

1217-1223

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/HRT.2003.027680

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

90

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8346262

http://www.w3.org/2001/XMLSchema#string

P698

15367530

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

P932

1768505

http://www.w3.org/2001/XMLSchema#string